Results 91 to 100 of about 32,473 (237)

Role of antimetabolites in recalcitrant idiopathic orbital inflammatory syndrome

open access: yesOman Journal of Ophthalmology, 2011
Background : High-dose systemic steroids are the primary modality of treatment for idiopathic orbital inflammatory syndrome (IOIS). Occasionally patients experience a relapse of symptoms on tapering steroids or require large doses of steroid ...
Yamini Priya   +2 more
doaj   +1 more source

Inhibition of antibody production by thioinosine. 3. Studies on antibody biosynthesis [PDF]

open access: yes, 1970
The effect of thioinosine on antibody response of immunized rabbits has been studied. When given simultaneously with the antigen, thioinosine profoundly suppresses the formation of humoral antibody.
Kumashiro, Kazuo, Ogata, Masana
core   +1 more source

In Vitro Antimicrobial Activity and In Vivo Intestinal Barrier Regulation by Commiphora leptophloeos Bark Extract in 5‐Fluorouracil–Induced Mucositis

open access: yesChemistry &Biodiversity, Volume 23, Issue 4, April 2026.
ABSTRACT This study evaluated the phytochemical composition, antimicrobial activity, and in vivo protective effects of the hydroethanolic extract from Commiphora leptophloeos stem bark (HECL) against 5‐fluorouracil (5‐FU)‐induced intestinal mucositis. Despite the extensive traditional use of C.
Stphannie Jamyla de Araújo Barbosa   +17 more
wiley   +1 more source

Ophthalmologists' practice patterns and challenges in achieving optimal management for glaucoma in Nigeria: results from a nationwide survey. [PDF]

open access: yes, 2016
PURPOSE OF THE STUDY: Glaucoma, a chronic non-communicable disease, and leading cause of irreversible blindness worldwide is a public health problem in Nigeria, with a prevalence of 5.02% in people aged ≥40 years.
Gilbert, Clare   +2 more
core   +1 more source

Clinical validation of a DNA methylation biomarker associated with overall survival of relapsed ovarian cancer patients

open access: yesInternational Journal of Cancer, Volume 158, Issue 7, Page 1821-1835, 1 April 2026.
What's new? Most patients with ovarian cancer (OC) relapse after first‐line chemotherapy, and prognosis with second‐line treatment depends largely on the platinum‐free interval. However, reliable biomarkers to predict response to second‐line therapy remain lacking.
Muhammad Habiburrahman   +7 more
wiley   +1 more source

Removal of antinutritional factors from bean (Phaseolus vulgaris L.) seeds [PDF]

open access: yesBiotechnologie, Agronomie, Société et Environnement, 1999
Phytohemagglutinin and the lectin-related proteins present in bean seeds are toxic to monogastric animals and lower the nutritional value of beans. Since these antimetabolites are present in substantial amounts, a breeding program aimed to the removal ...
Bollini R., Carnovale E., Campion B.
doaj  

Neutron activation analysis for antimetabolites [PDF]

open access: yes
Determination of metal ion contaminants in food samples is studied. A weighed quantity of each sample was digested in a concentrated mixture of nitric, hydrochloric and perchloric acids to affect complete solution of the food products.

core   +1 more source

Nurses\u27 Alumnae Association Bulletin, May 1957 [PDF]

open access: yes, 1957
Alumnae Notes Committee Reports Digest of Alumnae Meetings Graduation Awards - 1956 Letter from Hong Kong Leukemia Marriages Necrology New Arrivals Physical Advances at Jefferson President\u27s Message School of Nursing Report Two Year Programs in ...
Chan, Gertrude   +9 more
core   +1 more source

The clinical trial landscape of osteosarcoma: integrating trial data, immunotherapeutic trends, and biomarker insights

open access: yesFrontiers in Immunology
Osteosarcoma, the most aggressive primary malignant bone tumor, has stagnant therapeutic outcomes despite decades of standard MAP chemotherapy and surgery; 5-year overall survival (OS) is <30% for metastatic/recurrent cases.
Lifeng Ge   +5 more
doaj   +1 more source

Current Perspectives on the Use of Anti-VEGF Drugs as Adjuvant Therapy in Glaucoma [PDF]

open access: yes, 2016
The approval of one of the first anti-vascular endothelial growth factor (VEGF) agents for the treatment of neovascular age-related macular degeneration one decade ago marked the beginning of a new era in the management of several sight-threatening ...
Andrés Guerrero, Vanessa   +9 more
core   +4 more sources

Home - About - Disclaimer - Privacy